-

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of NANO Nuclear Energy Inc. (NNE) Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired NANO Nuclear Energy Inc. (“Nano” or the “Company”) (NASDAQ: NNE) securities between May 8, 2024 and July 18, 2024, inclusive (the “Class Period”). Nano investors have until October 8, 2024 to file a lead plaintiff motion.

If you suffered a loss on your Nano investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities laws, you can submit your contact information at www.glancylaw.com/cases/NANO-Nuclear-Energy-Inc/. You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at shareholders@glancylaw.com to learn more about your rights.

On July 19, 2024, Hunterbrook Media published a report alleging, among other things, that Nano “has no revenue, products, or patents for its core technology.” The report further specified that, as of July 2024, “the U.S. Nuclear Regulatory Commission [(“NRC”)] does not list [Nano] among the companies that have begun pre-application activities for the kind of reactor [Nano] is pitching,” and that an NRC spokesperson stated that the Advanced Reactor department is “not aware of this company” and “have not had any pre-application dealings with them.”

On this news, Nano’s stock price fell $3.33, or 17.3%, to close at $15.97 per share on July 22, 2024, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Nano’s purported progress toward regulatory approval for the design of its planned micro reactors and fuel fabrication plant was nonexistent; (2) Nano’s timelines for commercialization were wildly optimistic, at best, and most likely impossible; (3) the foregoing issues were likely to have a material negative impact on the Company’s projected revenues and growth; (4) as a result, the Company's financial position and/or prospects were overstated; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on LinkedIn, Twitter, or Facebook.

If you purchased or otherwise acquired Nano securities during the Class Period, you may move the Court no later than October 8, 2024 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Charles Linehan, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com
shareholders@glancylaw.com

Glancy Prongay & Murray LLP

NASDAQ:NNE

Release Versions

Contacts

Glancy Prongay & Murray LLP, Los Angeles
Charles H. Linehan, 310-201-9150 or 888-773-9224
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
www.glancylaw.com
shareholders@glancylaw.com

More News From Glancy Prongay & Murray LLP

Glancy Prongay Wolke & Rotter LLP Announces Investigation of Integer Holdings Corporation (ITGR) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it is investigating potential claims against the board of directors of Integer Holdings Corporation (“Integer” or the “Company”) (NYSE: ITGR) concerning whether the board breached its fiduciary duties to shareholders. IF YOU ARE AN INTEGER HOLDINGS CORPORATION (ITGR) SHAREHOLDER, CLICK HERE TO PARTICIPATE. What Happened? On October 23, 2025, before the market...

Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 21, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR CORCEPT INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTEN...

Two GPWR-Litigated Matters Featured in Broadridge’s 2026 Global Class Action Annual Report’s Top 10 Most Complicated Recoveries of 2025

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP (“GPWR”) announces that two matters the Firm litigated are spotlighted in Broadridge’s 2026 Global Class Action Annual Report among the “top 10 most complicated class action asset recovery opportunities of 2025”: Alibaba Group Holding Ltd. Securities Litigation ($433.5M) and ViacomCBS (Archegos) Securities Litigation ($120M). Congrats to the talented lawyers—Robert Prongay, Kara Wolke, Kevin Ruf, Melissa Wright, Pavithra Rajesh...
Back to Newsroom